TxSphere designed its technology to deliver drugs at a higher volume and higher viscosity than traditional autoinjectors.
Study met primary end point and demonstrated successful subcutaneous administration of a 10 mL biologic co-formulated with ENHANZE® in 30 seconds using Halozyme's proprietary high-volume auto-injector ...
The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and cluster headaches in adults, Amneal Pharmaceuticals announced Thursday. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results